PMID: 2499657Jun 1, 1989Paper

Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma

The Journal of Experimental Medicine
P BrouckaertW Fiers

Abstract

Plasma samples obtained from patients receiving a 24-h continuous infusion of human recombinant (hr)TNF or a combination of two overlapping, 24-h continuous infusions of hrIFN-gamma and hrTNF were analyzed for IL-6 in a sensitive bioassay. A transient appearance of circulating IL-6 was observed with peak levels between 3 and 6 h after the start of the hrTNF infusion. These peak levels correlated quite well with the dose of hrTNF administered (r = 0.86; p less than 0.001). The maximal value observed was 27.5 ng/ml IL-6 in a sample of a patient receiving 545 micrograms/m2 hrTNF. The combination of hrIFN-gamma (200 micrograms/m2) and hrTNF in the infusions resulted in higher IL-6 levels than a comparable dose of hrTNF alone. A maximal value of 23.5 ng/ml IL-6 was observed in a patient receiving 205 micrograms/m2 hrTNF. No IL-6 was found in the plasma of patients during the 12-h infusion with hrIFN-gamma alone, except for two borderline samples.

References

Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J Van SnickR J Simpson
May 1, 1988·Immunology Today·G G Wong, S C Clark
Nov 15, 1986·International Journal of Cancer. Journal International Du Cancer·P G BrouckaertW Fiers
Mar 1, 1988·The Journal of Infectious Diseases·K J TraceyA Cerami
Jun 1, 1988·The Journal of Experimental Medicine·A Waage, T Espevik

❮ Previous
Next ❯

Citations

Nov 1, 1992·Medicinal Research Reviews·J M ArgilésF J López-Soriano
Jan 1, 1993·Stem Cells·S de Kossodo, G E Grau
Jan 1, 1990·Urological Research·R Heicappell, R Ackermann
Mar 1, 1993·Transplant International : Official Journal of the European Society for Organ Transplantation·M H RaasveldR J ten Berge
Jan 1, 1996·Journal of Cancer Research and Clinical Oncology·T OhiraN Saijo
Jun 1, 1991·Annals of Hematology·J Bauer, F Herrmann
Jan 1, 1992·Cancer Immunology, Immunotherapy : CII·A S KooA Belldegrum
May 24, 2003·Best Practice & Research. Clinical Gastroenterology·Christian P Strassburg
Jul 10, 2013·Nature Medicine·Georg SchettMarkus F Neurath
Mar 1, 1990·The Journal of Experimental Medicine·J J MuléS A Rosenberg
Dec 26, 2001·The Journal of Experimental Medicine·W WaelputC Libert
Jul 11, 2001·Critical Care Medicine·J F DhainautC Vinsonneau
Mar 21, 2002·Critical Care Medicine·Fernández E DomínguezF U Schade
Oct 1, 1990·Scandinavian Journal of Immunology·E J von AsmuthW A Buurman
Apr 15, 1997·Annals of the New York Academy of Sciences·T BabaF Numano
Nov 1, 1991·The Journal of Clinical Investigation·C MunozJ M Cavaillon
May 1, 1994·The Journal of Clinical Investigation·C FerranL Chatenoud
Dec 1, 1992·The Journal of Pathology·M van DeurenJ W van der Meer
Apr 2, 2003·Archives of Biochemistry and Biophysics·Hiroaki KorekaneKiichi Imamura
Aug 30, 2014·Cytokine & Growth Factor Reviews·Lisa M Sedger, Michael F McDermott
Aug 1, 1998·Japanese Journal of Cancer Research : Gann·S NakataS Ogita
Nov 1, 1991·Cytokine·W L FarrarK A Clouse
Dec 1, 1993·Lupus·C Gordon, P Emery
May 20, 1998·JPEN. Journal of Parenteral and Enteral Nutrition·H R Chang, B Bistrian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.